<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="44978" whole_study_id="26784" phs="001473" v="2" p="2" createDate="2021-11-09T10:52:08-05:00" completedByGPADate="2022-05-23T15:55:18-05:00" modDate="2022-05-25T22:04:49-05:00" maxParentChildStudyModDate="2022-05-25T22:04:49-05:00" handle="Ibrutinib_Treated_CLL" num_participants="61"><StudyInfo accession="phs001473.v2.p2" parentAccession="phs001473.v2.p2"><BioProject id="PRJNA415268" entrez_id="415268" type="bp_admin_access"/><BioProject id="PRJNA415269" entrez_id="415269" type="bp_data_submission"/><StudyNameEntrez>The landscape of dynamic genetic changes in ibrutinib-treated CLL</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="tumor_normal"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>individual_sequencing</StudyType><StudyType>tumor_normal</StudyType><StudyType>targeted_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>R01 CA182461</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="CWU001" aid="2" auth="eRA" login="CWU001" fname="Catherine" mname="JU-YING" lname="Wu" email="cwu@partners.org"><Role allow_direct_access="true">PI</Role><Organization>DANA-FARBER CANCER INST</Organization></Person><Person nedid="0010173274" aid="1" auth="cit" login="jhappanc" fname="Chamelli" mname="" lname="Jhappan" email="jhappanc@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Alicia" lname="Wong" email="alitang@broadinstitute.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014392987" aid="1" auth="cit" login="fingerma" fname="Ian" mname="Michael" lname="Fingerman" email="fingerma@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>We thank all members of the Broad Institute&#8217;s Biological Samples, Genetic Analysis, and Genome Sequencing Platforms, who made this work possible (NHGRI-U54HG003067). CJW acknowledges support from NIH/NCI (1R01CA182461-02; 1R01CA184922-01, U10CA180861-01), and is a Scholar of the Leukemia and Lymphoma Society. DAL is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists, Stand Up to Cancer Innovative Research Grant, the Kimmel Scholar&#8217;s Award, the ASH Scholar Award, Leukemia Lymphoma Society translational research program and by the National Institutes of Health (NIH) Big Data to Knowledge initiative (BD2K, 1K01ES025431-01). The authors thank Ravi Ravichandran for protein modeling of PLCG2 mutations. This work was supported in part by the Intramural Research Program of the NIH/NHLBI (C.S., S.E.M.H., D.L., C.U., and A.W).</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2751" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="26784" whole_study_id="26784" phs="001473" v="1" p="1" createDate="2017-09-27T15:37:58-05:00" completedByGPADate="2017-09-27T15:50:13-05:00" modDate="2021-11-09T10:52:10-05:00" maxParentChildStudyModDate="2021-11-09T10:52:10-05:00" handle="Ibrutinib_Treated_CLL" num_participants="61"><StudyInfo accession="phs001473.v1.p1" parentAccession="phs001473.v1.p1"><BioProject id="PRJNA415268" entrez_id="415268" type="bp_admin_access"/><BioProject id="PRJNA415269" entrez_id="415269" type="bp_data_submission"/><StudyNameEntrez>The landscape of dynamic genetic changes in ibrutinib-treated CLL</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="tumor_normal"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>individual_sequencing</StudyType><StudyType>tumor_normal</StudyType><StudyType>targeted_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>R01 CA182461</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="CWU001" aid="2" auth="eRA" login="CWU001" fname="Catherine" mname="JU-YING" lname="Wu" email="cwu@partners.org"><Role allow_direct_access="true">PI</Role><Organization>DANA-FARBER CANCER INST</Organization></Person><Person nedid="0010173274" aid="1" auth="cit" login="jhappanc" fname="Chamelli" mname="" lname="Jhappan" email="jhappanc@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Alicia" lname="Wong" email="alitang@broadinstitute.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014392987" aid="1" auth="cit" login="fingerma" fname="Ian" mname="Michael" lname="Fingerman" email="fingerma@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>We thank all members of the Broad Institute&#8217;s Biological Samples, Genetic Analysis, and Genome Sequencing Platforms, who made this work possible (NHGRI-U54HG003067). CJW acknowledges support from NIH/NCI (1R01CA182461-02; 1R01CA184922-01, U10CA180861-01), and is a Scholar of the Leukemia and Lymphoma Society. DAL is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists, Stand Up to Cancer Innovative Research Grant, the Kimmel Scholar&#8217;s Award, the ASH Scholar Award, Leukemia Lymphoma Society translational research program and by the National Institutes of Health (NIH) Big Data to Knowledge initiative (BD2K, 1K01ES025431-01). The authors thank Ravi Ravichandran for protein modeling of PLCG2 mutations. This work was supported in part by the Intramural Research Program of the NIH/NHLBI (C.S., S.E.M.H., D.L., C.U., and A.W).</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2751" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>